Mölndal, Sweden

Johan Gottfries

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Molndal, SE (2000)
  • Göteborg, SE (2003)
  • Gothenburg, SE (2004 - 2014)
  • Mölndal, SE (2015)

Company Filing History:


Years Active: 2000-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Johan Gottfries

Introduction

Johan Gottfries is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory conditions. With a total of 5 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

Gottfries' latest patents focus on 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease. The present invention relates to various derivatives, including 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl)propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl)propionic acid derivatives, and benzoic acid derivatives. These compounds are designed for use in treating inflammatory conditions and are included in pharmaceutical compositions.

Career Highlights

Throughout his career, Johan Gottfries has worked with prominent companies such as AstraZeneca AB and Albireo AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Maria Boije and Anders Broo. Their collaboration has contributed to the advancement of research and development in the field.

Conclusion

Johan Gottfries is a distinguished inventor whose work in pharmaceuticals has led to important advancements in the treatment of inflammatory diseases. His patents and collaborations reflect his commitment to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…